The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.
Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.
If you missed our video discussion on AGBT day one, view it here. Don’t miss Julianna LeMieux’s GEN Live on March 2. We deliver a full debrief on the news from AGBT—critical to understanding where NGS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results